Medtronic buys GERD (gastroesophageal reflux disease) company Endonetics
This article was originally published in Clinica
Medtronic is to buy private company Endonetics, which develops technologies to diagnose and treat gastroesophageal reflux disease (GERD). Terms of the deal were not disclosed.
You may also be interested in...
China’s Bio-Thera Solutions has received approval from the country’s NMPA to launch a Phase I clinical study comparing the pharmacokinetics and safety of its proposed ustekinumab biosimilar to Johnson & Johnson’s blockbuster psoriasis drug Stelara, the latest in a string of the biotech company’s products to advance into clinical development.
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.